FDA Inspection
Opocrin SPAOpocrin SPA – FDA Inspection, May 6, 2016
Record Details
This FDA Inspection record concerns Opocrin SPA, with an inspection on May 6, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Opocrin SPA
- Inspection Date
- May 6, 2016
- Product Type
- Drugs
View Company Profile
ID · 39bc51a8-58f1-411f-bfab-244c92988c00
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 970807
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Opocrin SPA
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Opocrin SPA
- FDA Inspection 1169545 - 2022-02-25
- FDA Inspection 1092538 - 2017-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.